Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Bill Katz
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).
- Questions
- 86on tracked calls
- Challenge rate
- 3%3 of 86 questions
- Companies
- 12questioned at least once
- Reporting periods
- 8with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 86 of 86 questions from 12 companies
BENFranklin Resources12 questions · 8 reporting periods · 0 of 12 challenging
Calendar 2026 Q2
Can you unpack where you’re seeing the strength, and where you might be in terms of Lexington XI and the outlook for that
Show response
Johnson quantified the raise at $33 billion year-to-date versus a $25 billion to $30 billion target, guiding to about $40 billion; Lexington was about 40% of the quarter's $10.3 billion. Direct.
Is 30% plus the endpoint, or is that just a stop along the route?
Show response
Johnson said 30% is a stop along the route, expecting margin above 30% over time; Nicholls framed 30% to 35% as the industry zone. Direct.
Calendar 2026 Q1
there has been discussion around a potential adverse tax rule for Exchange 351
Show response
Jenny: Lexington XI expected at least size of Fund X (~$22.7B), on track with good demand. On 351 tax: ICI discussion is about making mutual fund treatment fairer, not removing ETF advantage. Daniel: Franklin ETFs don't use options overlays in that structure; MOST (SMA options) unaffected by discussion. On capital: dividend first, organic growth (seed/co-invest to $3B), employee share repurchase, opportunistic buyback, active M&A mostly distribution and alt bolt-ons.
Calendar 2025 Q4
To the extent that the market were to be a bit under pressure as the year goes by, how much flex do you have to sort of bring that number down?
Show response
Matt detailed expense cadence: add Q1+Q2 guidance, then split remainder evenly across Q3/Q4 with larger savings realization. 20% of $200M realized in Q1, rest spread over next three quarters with larger amounts in Q3/Q4. Margin expansion to high 20s in Q3/Q4. Q1 margin lower by ~2% from accelerated deferred comp.
can you just remind us what the variable expenses against net asset value were happening by the incremental margin on market action
Show response
Matt confirmed 35-40% variable expense ratio providing downside protection. Jenny on Western: DOJ declined criminal charges, investment team stable, $6.6B gross sales, integrating corporate functions. On alts: $9.5B private markets from 33+ vehicles without Lexington flagship. Fund XI targeting Fund X size (~$25B), first close expected this year.
Calendar 2025 Q3
how you sort of see maybe the opportunity in particular for tokenization, how that might impact the ability to drive performance
Show response
Jenny detailed: significantly cheaper to run tokenized funds, $20 minimum vs $500 traditional. Calculate yield every second, pay daily 365 days/year. Partial-day yield for collateral use. Binance partnership (270M wallets) for tokenized ETF distribution on crypto exchanges. Vision: all mutual funds and ETFs eventually tokenized due to efficiency.
Calendar 2025 Q2
How do you see this shifting the potential economic value proposition with the distribution partners?
Show response
Jenny detailed Benji as only digitally native on-chain money market fund. Patent on wallet operating across 8 blockchains. Managing reserves for 4 stablecoin providers plus first state-issued stablecoin. Blockchain disintermediates toll-takers via smart contracts, ownership entitlement, and payment mechanism. White-label conversations now happening in US after Genius Act clarity.
How do we think about where you might be sitting in terms of those conversations with the regulators
Show response
Jenny noted Franklin fixed income now largest SIM in institutional pipeline (unheard of 5 years ago). Western gross sales increasing, performance near 90th percentile. Outflows from $37B in December to $4.1B in June to $3B in July. Matt stated no reserve update. Capital priorities: dividend, organic growth, employee share repurchases, $100M debt deleveraging, potential $450M debt paydown next year.
Calendar 2025 Q1
Was the $10 billion was that the net of the $5 billion or is that the net outflows
Show response
Jenny confirmed $10B is net outflows inclusive of $5B gross sales. Strategically, prefers having alt capabilities under one umbrella vs alliances. Open to partnerships (e.g., Apollo in DC space) but believes own platform is advantaged.
Calendar 2024 Q4
what I think I heard was you'd be flat to '25 if you strip out market action, performance fees, and pre-synergies
Show response
Matt confirmed expense math: FY2025 flat (ex-perf fees, normalized for Putnam), then minus $200-250M for FY2026. Not assuming zero Western contribution, will provide monthly AUM updates with Western effective fee rate of 16.5bp.
Calendar 2024 Q3
I'm wondering whether or not the WAMCO overhang is affecting gross sales in any of the segments
Show response
Jenny confirmed outflows concentrated in Western's core/core plus/macro ops (~$90B). Some headline-risk redemptions but no material spillover to other SIMs.
I'm intrigued by your commentary of potentially revamping some of the economic relationships with the franchise
Show response
Matt explained Western is 8-9% of adjusted revenue, 5th-6th largest SIM by revenue. $53B outflows imply ~20% Western revenue decline, ~2% at Franklin level. Working through economic adjustments.
IVZInvesco12 questions · 7 reporting periods · 0 of 12 challenging
Calendar 2026 Q2
Maybe prioritize how you are thinking about capital return. Are you looking to do more deals now?
Show response
Dukes sequenced the revolver ahead of more preferred repurchases, put the preferred timing at later this year or early next, and said organic returns have beaten inorganic options.
as you think about either the incremental margin or maybe the longer term margin targets
Show response
Dukes reaffirmed a high-30s margin objective and repeated the $15 million per quarter implementation and $10 million platform-fee run rates from Q1 guidance.
Calendar 2026 Q1
how do you sort of see Invesco position as we move from pretax after tax
Show response
Andrew highlighted ETFs (inherent tax efficiency), SMAs ($40B platform with tax optimization as key feature), and model portfolios as three vehicles well-positioned for after-tax return trend. Primarily a U.S. phenomenon with no specific regulatory changes on horizon.
Can you give us an update on how you're thinking about maybe the intermediate to longer-term opportunity for margins at this point in time?
Show response
Allison confirmed mid-30s margin achieved, now targeting high-30s through disciplined expense management, simplification efforts, and scale benefits. Andrew added that highest-growth areas (ETFs, China) scale particularly well for profit growth.
Calendar 2025 Q4
can you talk a little bit about the priorities to bring down the remaining preferred and how you're sort of thinking about capital deployment more broadly?
Show response
Allison outlined near-term focus on revolver paydown and 5-year term loan, with ongoing MassMutual discussions for future preferred repurchase. Share buybacks increasing to $40 million in Q1. M&A remains opportunistic but organic investment and partnerships are priority.
can you talk a little bit about just the off-ramp on the implementation costs? I presume that should trend towards 0
Show response
Allison confirmed implementation costs will disappear over 2027, with additional savings from decommissioning existing systems, partially offset by ongoing AUM-on-platform costs.
Calendar 2025 Q3
I'm sort of curious if you could maybe put any kind of meat on the bone a little bit around where you are relative to the quorum or the approval rate
Show response
Allison declined to share specific quorum numbers but confirmed overwhelming majority voting in favor. Marketing expense reclassification is purely accounting-driven from SEC comments, no change to approximately 4 bps operating income impact.
Calendar 2025 Q2
Maybe picking up on the QQQs. Just a couple of questions that were embedded in my first question. Maybe why now?
Show response
Andrew framed the QQQ conversion as part of broad value-unlock effort. Allison clarified marketing budget would be $60-100 million (2-3 bps at discretion), and approximately 4 bps would flow to net revenue and operating income with no additional operating expenses.
Calendar 2025 Q1
are allocation dynamics shifting, and if so, to where might they be shifting?
Show response
Andrew noted institutions pausing future allocation decisions but not stopping existing fundings. Conversations active with clients seeking consultation and solutions.
There's an increasing focus for that market to potentially have greater allocation to alternatives
Show response
Andrew highlighted existing private market strategies, Barings partnership potential for DC products, and global retirement opportunities including UK and Asia Pacific.
Calendar 2024 Q4
what percentage of your assets would you anticipate being migrated over in 2025?
Show response
Allison declined to share wave migration percentages but confirmed substantially all public market assets will ultimately move to alpha platform.
speak to your strategy to grow private markets. You gave a little bit of a detailing retail democratization and maybe what you can grow three beyond INCREF
Show response
Andrew outlined organic private market growth through wealth management channels, plus partnership-based inorganic expansion. Allison noted 60% payout target balanced against debt maturities.
RJFRaymond James Financial12 questions · 6 reporting periods · 0 of 12 challenging
Calendar 2025 Q4
if you could unpack maybe the Clark transaction a little bit, how to think about the accretion to that
Show response
Shoukry detailed three criteria: cultural fit (Card family alignment), strategic fit (maintaining Clark's independence and brand), and financials. Active corporate development apparatus with significant capital. Looking for deals across all businesses but won't force them.
Can you talk a little bit about the path to support the interest-earning asset growth from here
Show response
Shoukry detailed January sweep balance decline: $2.6B total ($2.1B sweep, $500M ESP) including $1.8B fee billing. Remaining decline from client reinvestment into markets. SBL grew nearly $2B in Q1 alone. Funding from diversified sources: sweep cash, third-party redeployment, TriState Capital Bank deposit gathering.
Calendar 2025 Q3
Can you help us maybe ring-fence this a little bit of any kind of guidepost for nonoperating expense
Show response
Shoukry pointed to 20%+ adjusted pretax margin target from Investor Day, to be updated at next Analyst Day in May/June. Proud of achieving 20% margin while investing heavily in growth. Technology investment increasingly differentiating from smaller competitors.
Would you look to maybe bring some of the third-party sweep deposits back on to balance sheet, run off some of the investment securities portfolio
Show response
Shoukry confirmed multiple funding levers: bring third-party bank deposits on-balance-sheet, continue running down securities portfolio, and leverage diversified treasury management capabilities across Raymond James Bank and TriState Capital Bank.
Calendar 2025 Q2
does that have any structural impact on your comp ratio
Show response
Shoukry characterized impact as a glide path rather than sudden change given the massive $1.6T asset base. Magnitude of new recruitment would need to be very substantial to move firm-wide ratios.
Wondering if you could update us on your thoughts about how the strategic backdrop is looking from an M&A perspective
Show response
Shoukry detailed active corporate development across spectrum from early to advanced discussions. PCG is top acquisition priority, then capital markets and asset management. Bank already has 2 charters with utility-style structure. Three criteria: cultural fit, strategic fit, attractive valuation.
Calendar 2025 Q1
I was wondering if you could give us maybe the nature of the kind of transactions you were looking at
Show response
Shoukry declined to discuss specific M&A targets. Confirmed 10% Tier 1 leverage target remains appropriate. Framed $400-500M quarterly buyback pace as keeping ratios stable while preserving M&A capacity.
how do you see the intermediate term view for earning asset growth? Is it flattish here or a remix within the loan category
Show response
Oorlog detailed AFS maturities of $350M in Q2, approximately $275M in Q3, and $325M in Q4 being redeployed into loans. Shoukry noted SBL continues growing through April volatility but corporate loan demand remains tepid.
Calendar 2024 Q4
Wondering when you can sort of prioritize where you're most interested in growing the platform
Show response
Shoukry ranked PCG as top M&A priority, then capital markets (team hires/niche acquisitions), then asset management (only with good organic growth profiles). Reilly highlighted geographic opportunity in Northeast and West Coast.
How much flex is that if the revenue backdrop were to, potentially, decay a little bit just from a macro perspective
Show response
Shoukry noted most non-comp growth is revenue-correlated (sub-advisory fees, branch expense, FDIC insurance). Committed to long-term 3-5 year investment horizon regardless of short-term macro.
Calendar 2024 Q3
are you seeing a structural shift in the client cash? Or is this more of a timing element on asset allocation
Show response
Shoukry noted asset mix remarkably consistent with equities at roughly 60%. Shift has been within cash category between transactional and investable cash. Sorting deceleration now revealing organic growth.
how do we think about the marginal margin in those segments? And then coming back Paul to your comments
Show response
Shoukry cautioned against assuming margin improvement across all segments simultaneously. Capital markets margin benefited from loss reversal in Q4 but first three quarters were weak. Puts and takes are natural.
ARESAres Management Corporation8 questions · 7 reporting periods · 0 of 8 challenging
Calendar 2026 Q2
Sort of intrigued by your comment that you should be accelerating toward the upper end of your 0 to 150 basis points.
Show response
Jarrod cited new products (data center, GCP integration post-TSA), the biennial AGM expense normalizing out, and deployment-driven revenue as margin drivers, while stressing reinvestment for growth.
Calendar 2026 Q1
On the realization side, Q1 came out a little lighter than many of us anticipated. It sounds like there is momentum not only for you but the industry at large
Show response
Phillips explained that extended durations in credit waterfalls actually increase accrued balances, reiterated full-year realization guidance, and noted flexibility for FRE margin expansion including data center business shifting from FRE-negative to positive.
Calendar 2025 Q4
real assets, specifically real estate. And then the secondary platform is just another form of liquidity
Show response
Mike detailed flagship credit fund timelines: ASOF III final close Q1 at or above prior $7.1B vintage; Pathfinder III launched, expected done by summer at or above $6.6B plus $3.5B extension; SDL IV first close potentially Q4 2025; EDL VII early 2027. Real estate values down 18-20% with undersupply and rate tailwinds. Secondaries doubled since Landmark acquisition.
Calendar 2025 Q3
wondering if you could talk a little bit about the growth opportunity, whether it be on the infrastructure side or the real estate side
Show response
Jarrod highlighted GCP's role in making Ares a top-3 alternative real estate manager. Data center sites are urban-adjacent, low-latency, attractive to cloud computing with AI optionality but not AI-dependent. $6B in ground for development. Self-storage business also seeing meaningful tailwinds.
Calendar 2025 Q2
how your conversations are going with some potential partners and how you sort of see the opportunity set for Ares
Show response
Mike noted product ready to go with retirement services conversations ongoing. Tempered enthusiasm by stressing tension between capital base and investable opportunity. Warned against disproportionate focus on AUM growth versus quality deployment.
Calendar 2025 Q1
how did the platform hold-up through the turbulence of April post Liberation Day?
Show response
Mike reported steady April flows of $1.2B equity, no increase in redemptions during CADC April 10th redemption period. Two new products added: tax-advantaged infrastructure BDC and sports/media/entertainment.
Calendar 2024 Q4
Does this give you an opportunity to rethink the mass affluent marketplace without compromising fee rates?
Show response
Mike emphasized any partnership product must be client-led and differentiated, not just bundling alternatives with traditional assets. Noted T. Rowe complementary distribution but stressed it is too early to tell.
is there an opportunity to sort of reroute some of the compensation against that?
Show response
Jarrod noted European waterfall provides flexibility but needs to be established before meaningfully impacting compensation. Full benefit expected after year one or two of waterfall kick-in.
CMECME Group8 questions · 6 reporting periods · 0 of 8 challenging
Calendar 2026 Q2
what are the top two or three priorities as you're ready for the new role?
Show response
Lynne signaled continuity of strategy; Terry outlined the 60-day CFTC response window landing in August with a judge assigned.
Calendar 2026 Q1
I think you affirmed your guidance for $1.695 billion for the year. Can you sort of unpack what the growth was in Q1
Show response
Lynne attributed Q1 expense growth to variable costs from record activity, particularly compensation and technology. Expects occupancy to grow with Dallas facility and technology costs to rise with cloud migration.
if you can update us on your thinking on capital allocation at this point in time
Show response
Terry emphasized commitment to dividend and share repurchase but left door open for M&A if the right opportunity arises within CME's scope. Currently in a strong position on both dividend and buyback.
Calendar 2025 Q4
How do we think about maybe the prospective approach to capital?
Show response
Lynne confirmed OSTTRA proceeds being deployed to repurchases over time. Julie emphasized data is core trading input, not susceptible to AI disruption. Terry views AI as enhancing, not disrupting CME's data business.
Calendar 2025 Q2
given the interplay of sort of a rising non-U.S. rising retail opportunity set relative to the base business and sort of the volume growth, how are you thinking about maybe the projection for RPC
Show response
Lynne acknowledged competing RPC forces: international non-member activity (higher RPC) vs retail micro trading (lower RPC). Focus is on total revenue growth.
Calendar 2025 Q1
if you could unpack some of the drivers for that growth, how much that might be sort of onboarding new users versus maybe penetration of that user base
Show response
Julie highlighted commercial participants up almost 30%, record non-US options growth of 1.5M ADV up 20% YoY, and buy-side strength in both EMEA and APAC.
Calendar 2024 Q4
your pricing in futures and options was up 1.5% to 2%, and I think I heard today a little bit lesser rate, about 1% to 1.5%
Show response
Lynne explained the mix shifted away from clearing fees toward collateral fees. Changes concentrated in crypto, metals (micro and options), nat gas, and grains.
what is the most recent update as it relates to the competitive backdrop on the interest rate contract and the US Treasury contract
Show response
Terry made a forceful case for US resolution authority over sovereign debt clearing, citing Secretary Bessent's comments. Positioned CME's argument as gaining traction.
APOApollo Global Management7 questions · 7 reporting periods · 1 of 7 challenging
Calendar 2026 Q2
I just want to come back to the opportunity to sort of achieve the 11% return for the alternative sleeve within Athene.
Show response
Rowan expressed optimism Athora is set up for mid-teens returns after folding excess overhead into operating subsidiaries, with AAA nearing its 10% target.
Calendar 2026 Q1
How are you prioritizing capital return from here? Should we assume you have enough organic growth to get there?
Show response
Rowan stated the bar for acquisitions is very high given technology now makes building challenger businesses nearly free. Prefers aggressive stock buybacks in risk-off markets and organic growth.
Calendar 2025 Q4
How that may influence the opportunity set in, 27% to 20% FRE margin profile?
Show response
Zelter framed future origination growth as geographic expansion: Europe and Asia-Pac. Rowan described Apollo Sports Capital model as template for ecosystem strategies. Kelly guided ~100bp annual FRE margin expansion.
Calendar 2025 Q3
One of the pushbacks we get for Apollo and the industry at large is just as rates come down, the demand for yield or income will come down
Show response
Rowan reframed the narrative: investors are reducing equity risk, not chasing yield. Apollo in risk reduction mode, top of capital structure, lower leverage. Zelter added secular demand from global retirees overwhelms cyclical spread dynamics.
Calendar 2025 Q2
what has changed in the last couple of quarters here? Is it just the breadth of clients that you're working for? Is it the capacity at the origination platform?
Show response
Zelter attributed the acceleration to the integrated toolbox effect under consolidated origination leadership, ATLAS scaling from 200 to 300 facilities, and the flywheel of combined capital solutions.
Calendar 2025 Q1
you have KKR now with Capital Group, Blackstone working with Wellington and others. Where do you stand in terms of maybe a broader linkage to potentially participate in that?
Show response
Rowan described two announced partnerships (State Street, Lord Abbott) and framed traditional asset managers as a major new demand source. Emphasized these are early experiments and origination is the binding constraint.
Calendar 2024 Q4
you think you can make progress within the retirement accounts even if there's no improved legislation. I was wondering if you could maybe expand on A, how you do that?
Show response
Rowan gave an extensive, detailed answer covering 401(k) market structure, target date fund limitations, regulatory outlook, and specific product channels. Highly engaged response.
Show 6 more companies
BXBlackstone Inc.7 questions · 7 reporting periods · 1 of 7 challenging
Calendar 2026 Q2
Any thoughts of maybe rejiggering the payout rate stepping in on buyback a little bit versus an overgrowth?
Show response
Chae reaffirmed the policy of returning 100% of cash earnings via dividend plus a moderate buyback, noting scope to be more opportunistic on the stock over time.
Calendar 2026 Q1
I was wondering if you could maybe step back and talk a little bit about what you're seeing in terms of institutional allocations
Show response
Gray credited Joe Dowling for BXMA performance inflection. Highlighted 24 consecutive quarters of positive returns and 250bps annual premium. Added that away from BCRED, other products had a good quarter.
Calendar 2025 Q4
One of the biggest pushbacks is as rates continue to work their way lower, the relative appeal of income-oriented vehicles is going down. So I was wondering, a, what are you hearing on the evolutio...
Show response
Gray emphasized breadth of offerings across income, growth, and hybrid products. Private credit appeal rests on relative premium over liquid fixed income, not absolute returns, as proven by BCRED's success in zero-rate environment.
Calendar 2025 Q3
Any thoughts on how we should think about the comp within the FRE versus the comp on gross realizations?
Show response
Chae noted healthy FRE margin dynamics with operating leverage over time, and ability to allocate compensation between FRE and performance revenue categories.
Calendar 2025 Q2
can you unpack a little bit how you sort of see the interplay for the FRE margin? A very strong quarter this quarter
Show response
Chae noted sensitivity to FRPR, seasonally higher H2 OpEx, but reiterated low double-digit OpEx growth for full year and stability as a margin guidepost.
Calendar 2025 Q1
I was wondering if you could maybe flesh out how that may come together in terms of products or opportunities
Show response
Gray described the alliance as creating holistic public-private solutions for individual investors, noting Blackstone's 300+ person global wealth distribution team.
Calendar 2024 Q4
How do you see the evolution of the commentary coming out of your conversations with the regulators as that takes shape into 2025 on the Trump administration
Show response
Gray argued the 401(k) market should eventually include alternatives, noting Blackstone's unique positioning with brand, performance, and perpetual product range.
SCHWCharles Schwab Corporation7 questions · 7 reporting periods · 1 of 7 challenging
Calendar 2026 Q2
I'm just sort of curious if we could dive into the share count outlook and maybe the broader question on capital return
Show response
Prioritizes funding client growth first, then opportunistic buybacks; repurchased $1 billion of common shares; open to M&A.
Calendar 2026 Q1
you're doing a better job of managing the interplay between balance sheet growth and capital return
Show response
Verdeschi highlighted accretive lending growth, 19% dividend increase, potential preferred redemption decisions ahead, and strong buyback flexibility driven by robust earnings growth.
Calendar 2025 Q4
maybe you can unpack why only 5%? Are you still thinking 5% to 7% is the right long-term goal?
Show response
Rick noted total client assets grew 18% YoY so the 5% target base keeps growing. Long-term believes above 5% achievable with crypto, workplace, and retail relationship investments. Mike confirmed 6.75-7% adjusted Tier 1 ratio objective unchanged.
Calendar 2025 Q3
how should we think about the interplay between interest earning asset growth and capital return
Show response
Mike noted interest-earning assets likely modestly growing in 2026 from client lending. Strong earnings building capital organically to support both franchise growth and multi-form returns.
Calendar 2025 Q2
Wondering how you think about maybe redeploying that to balance sheet growth versus other initiatives
Show response
Mike outlined strategy of supporting client lending needs then resuming securities purchases at accretive yields, building durable earnings and organic capital for return.
Calendar 2025 Q1
how are you thinking about balance sheet growth into the second half of this year or maybe 2026
Show response
Mike noted securities portfolio yields sub-2% with reinvestment at current rates being highly accretive, supporting continued earnings growth and organic capital formation.
Calendar 2024 Q4
Can you talk to us through a little bit in terms of the ins and outs, and how you sort of see it
Show response
Mike emphasized growth strategy with bank platform central to objectives, noting tactical flexibility to move liquidity off balance sheet when appropriate.
KKRKKR5 questions · 5 reporting periods · 0 of 5 challenging
Calendar 2026 Q1
What do you think is a normalized level of ROE and maybe the time line to get to that?
Show response
Rob noted GA didn't hit targeted return in Q1 due to volatility, with target being low double digits. Emphasized buying 100% of GA was driven by desire to capitalize on volatility when it comes.
Calendar 2025 Q4
how do you sort of see the evolution of the flows in wealth management, which had been driven heavily by private credit over the last couple of years?
Show response
Craig Larson shared January K-Series inflows ~$1.3B, up ~20% YoY despite volatility. Q4 $4.5B was up 8% QoQ. No change in long-term wealth opportunity view. Scott added no change in deployment or return expectations; noted this is 10th time stock down 20%+ in a month during 16-17 years public, historically a great entry point.
Calendar 2025 Q3
as you think about the ROE trajectory for the insurance business, what do you think is a normalized level, and when do you get there?
Show response
Rob pointed to Page 20 total economics ($1.8B LTM) plus ~$200M annual accrued income not in numbers. Confirmed $7+ ANI confidence for 2026 but acknowledged monetization dependency. TOE target less relevant due to cash/accrued dynamics.
Calendar 2025 Q2
I'd be curious, maybe get a little bit of a refresh of just number of origination platforms you have and why you think that could translate into the ability to generate further alpha?
Show response
Craig cited 35 origination platforms, ~$30-35B annual IG origination. Scott drew parallels to PE scaling 20 years ago, noting 7,500 people sourcing across 19 ABF platforms with HCR adding another.
Calendar 2024 Q4
Just sort of wondering where you sort of see the greatest opportunity. I know it's a fairly in-depth question just from a multi vector perspective
Show response
Craig detailed $100B individual AUM, K-Series strength in PE/infra with leading market share. Scott positioned Capital Group as access to mass affluent. Rob noted distribution costs are clear ROI.
BLKBlackRock3 questions · 3 reporting periods · 0 of 3 challenging
Calendar 2025 Q3
how your conversations with maybe the consultant community, the regulators, the legislators are going around sort of this change?
Show response
Martin reported positive momentum from President's executive order, draft safe harbor provisions, and ERISA class exemptions. BlackRock at $585B target date AUM. Expects smaller adviser-sold plans to be first movers. Proprietary LifePath with privates in 2026.
Calendar 2025 Q2
How do you think about capital returns? It seems like you're going to be generating a ton of free cash flow
Show response
Martin reiterated invest-first strategy, $375M quarterly buyback, 40-50% dividend payout ratio. Dividend CAGR over 15% since 2003. Targeting high-single to low-double-digit dividend growth under 2030 strategy.
Calendar 2024 Q4
how are you thinking about maybe the payout relative to the earnings power?
Show response
Martin reiterated consistent capital allocation: invest first organically and inorganically, then dividend, then buyback as output. Returned $4.7 billion to shareholders in 2024; targeting $1.5 billion in share repurchases for 2025.
TROWT. Rowe Price3 questions · 3 reporting periods · 0 of 3 challenging
Calendar 2026 Q2
How are you thinking strategically to reshape the business given the fee rate is going down
Show response
Sharps laid out priorities: protect active equity, grow fixed income and alternatives, expand ETF/SMA vehicles, and pursue selective M&A. Direct and comprehensive.
Calendar 2025 Q3
Can you maybe frame out some of the savings you could see on the real estate side
Show response
Jen outlined three key actions: headcount reduction, technology sourcing strategy, real estate portfolio optimization. Rob reframed as purposeful investment reallocation, not belt tightening.
Calendar 2024 Q4
you announced a venture with Ares and Aspida. And I was just sort of wondering if you could tie together a couple of points associated with that
Show response
Rob gave comprehensive answer covering Aspida, insurance opportunity, and alternatives in DC, thorough multi-part response.
NDAQNasdaq, Inc.2 questions · 2 reporting periods · 0 of 2 challenging
Calendar 2026 Q1
can you maybe step back and help us frame out the Agentic AI capabilities for the Nasdaq platform itself?
Show response
Friedman outlined $100M internal AI efficiency target by end-2027 focused on product development automation, client implementations and enterprise functions. Client-side AI strongest in anti-fincrime workflows with capabilities expanding into surveillance and AxiomSL cloud offerings.
Calendar 2025 Q2
where you see the greatest opportunities, both from a volume perspective and perhaps even from an efficiency perspective for the platform
Show response
Friedman highlighted stablecoin efficiency for payment rails, Calypso proof of concept for on-chain collateral management, and market structure opportunities for crypto as regulated asset.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| BEN Franklin Resources | 12 | 0%none of 12 questions |
| IVZ Invesco | 12 | 0%none of 12 questions |
| RJF Raymond James Financial | 12 | 0%none of 12 questions |
| ARES Ares Management Corporation | 8 | 0%none of 8 questions |
| CME CME Group | 8 | 0%none of 8 questions |
| APO Apollo Global Management | 7 | 14%1 of 7 questions |
| BX Blackstone Inc. | 7 | 14%1 of 7 questions |
| SCHW Charles Schwab Corporation | 7 | 14%1 of 7 questions |
| KKR KKR | 5 | 0%none of 5 questions |
| BLK BlackRock | 3 | 0%none of 3 questions |
- BENFranklin Resources · 12 questions0%none of 12 questions
- IVZInvesco · 12 questions0%none of 12 questions
- RJFRaymond James Financial · 12 questions0%none of 12 questions
- ARESAres Management Corporation · 8 questions0%none of 8 questions
- CMECME Group · 8 questions0%none of 8 questions
- APOApollo Global Management · 7 questions14%1 of 7 questions
- BXBlackstone Inc. · 7 questions14%1 of 7 questions
- SCHWCharles Schwab Corporation · 7 questions14%1 of 7 questions
- KKRKKR · 5 questions0%none of 5 questions
- BLKBlackRock · 3 questions0%none of 3 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 4 | 0%none of 4 questions | 2 |
| 2024 Q4 | 15 | 0%none of 15 questions | 11 |
| 2025 Q1 | 10 | 0%none of 10 questions | 8 |
| 2025 Q2 | 13 | 0%none of 13 questions | 11 |
| 2025 Q3 | 11 | 9%1 of 11 questions | 10 |
| 2025 Q4 | 12 | 17%2 of 12 questions | 9 |
| 2026 Q1 | 11 | 0%none of 11 questions | 9 |
| 2026 Q2 | 10 | 0%none of 10 questions | 8 |
- 2024 Q34 questions · challenge rate 0% (none of 4 questions) · 2 companies
- 2024 Q415 questions · challenge rate 0% (none of 15 questions) · 11 companies
- 2025 Q110 questions · challenge rate 0% (none of 10 questions) · 8 companies
- 2025 Q213 questions · challenge rate 0% (none of 13 questions) · 11 companies
- 2025 Q311 questions · challenge rate 9% (1 of 11 questions) · 10 companies
- 2025 Q412 questions · challenge rate 17% (2 of 12 questions) · 9 companies
- 2026 Q111 questions · challenge rate 0% (none of 11 questions) · 9 companies
- 2026 Q210 questions · challenge rate 0% (none of 10 questions) · 8 companies
Topics
Topics tagged on this analyst’s questions.
- Margin31
- Capital Allocation22
- Competitive Dynamics16
- M&A15
- Demand14
- Subscriber Growth13
- Cost Pressure9
- Revenue Growth8
- Product Launch8
- Regulation Policy7
Show all 18 topics
- Innovation & R&D7
- Pricing5
- Credit4
- Guidance Reliability3
- Geographic Expansion3
- Capex Investment2
- Cloud & AI1
- Macroeconomic1